Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;8(3):e60156.
doi: 10.1371/journal.pone.0060156. Epub 2013 Mar 20.

Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma

Affiliations

Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma

Emmanuel S Buys et al. PLoS One. 2013.

Abstract

Primary open angle glaucoma (POAG) is a leading cause of blindness worldwide. The molecular signaling involved in the pathogenesis of POAG remains unknown. Here, we report that mice lacking the α1 subunit of the nitric oxide receptor soluble guanylate cyclase represent a novel and translatable animal model of POAG, characterized by thinning of the retinal nerve fiber layer and loss of optic nerve axons in the context of an open iridocorneal angle. The optic neuropathy associated with soluble guanylate cyclase α1-deficiency was accompanied by modestly increased intraocular pressure and retinal vascular dysfunction. Moreover, data from a candidate gene association study suggests that a variant in the locus containing the genes encoding for the α1 and β1 subunits of soluble guanylate cyclase is associated with POAG in patients presenting with initial paracentral vision loss, a disease subtype thought to be associated with vascular dysregulation. These findings provide new insights into the pathogenesis and genetics of POAG and suggest new therapeutic strategies for POAG.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: Peter Brouckaert: The Flemish Institute for Biotechnology receives a fee from a nonexclusive license of sGCα1−/− mice to the pharmaceutical industry. This study was partly funded by an Allergan Horizon grant. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Figures

Figure 1
Figure 1. Localization of sGC α1 and β1 subunits in the human and murine eye.
Panels A–C depict tissue sections from human eyes. Panels D–F depict tissue sections from mouse eyes. A: Ciliary muscle (CM), stained for α-smooth muscle actin (red), sGCα1 (green, upper panel), or sGCβ1 (green, lower panel). Both sGCα1 and sGCβ1 co-localized with α-smooth muscle actin in CM (yellow in merged images). Scale bars: 100 μm. B: An arteriole in the iris (IA) and an arteriole in the retina (RA) were stained for α-smooth muscle actin (red), sGCα1 (green, upper panels), or sGCβ1 (green, lower panels). Both sGCα1 and sGCβ1 co-localized with α-smooth muscle actin in the smooth muscle cell layer of arterioles in the iris and retina (yellow in merged images). ONL: outer nuclear layer, INL: inner nuclear layer. Scale bars: 20 μm. C: sGCα1 (left panel) and sGCβ1 (right panel) expression was detected histologically in the outer nuclear layer (ONL), inner nuclear layer (INL), and ganglion cell layer (GCL, white arrow) of the retina. sGCα1 and sGCβ1 are visualized by green fluorescence. Scale bars: 20 μm. D: Adjacent sections of a wild-type (WT) murine eye were stained for α-smooth muscle actin (green, left panel) or sGCα1 (red, right panel). sGCα1 co-localized with α-smooth muscle actin in ciliary muscle (CM) and in arterioles in the ciliary body (CA). The iridocorneal angle is indicated. Scale bars: 50 μm. E: Adjacent sections of a WT murine eye were stained for α-smooth muscle actin (green, left panel) or sGCα1 (red, right panel). sGCα1 co-localized with α-smooth muscle actin in retinal arterioles (RA). Scale bars: 50 μm. F: sGCα1 (left panel) and sGCβ1 (right panel) expression was detected histologically in the outer nuclear layer (ONL), inner nuclear layer (INL), and ganglion cell layer (GCL, white arrow) of the mouse retina. sGCα1 is visualized by brown peroxidase stain and sGCβ1 is visualized by green fluorescence. Scale bars: 20 μm.
Figure 2
Figure 2. Retinal nerve fiber layer (RNFL) thinning and glaucomatous optic neuropathy in sGCα1 −/− mice. A
: Quantitative analysis, assessed by SD-OCT (see also fig. S1), of total retinal thickness (left panel) and RNFL thickness, in young (6-week-old, middle panel) and old (70-week-old, right panel) wild-type (WT, n = 19 and 13, respectively) and soluble guanylate cyclase α1-deficient (sGCα1 −/−) mice (n = 15 and 14, respectively; *P = 1.2×10−2). B: Representative whole-mount retinas from age-matched young (20-week-old) and old (56-week-old) WT and sGCα1 −/− mice, reacted with antibodies directed against SMI32, staining retinal nerve fibers yellow. Scale bars: 500 μm. C: Representative confocal images, taken at a similar distance from the optic nerve, of flat-mounted retinas isolated from age-matched 52-week-old WT and sGCα1 −/− mice that were reacted with antibodies directed against βIII Tubulin, and quantitative analysis of the number of RGCs/high-powered field (n = 8 and 7, respectively; *P = 3.6×10−2). A retinal ganglion cell (red) is indicated by an arrow. Scale bars: 20 μm. D: Representative cross sections through the optic nerve of 52-week-old WT and sGCα1 −/− mice stained with paraphenylenediamine, and quantitative analysis of the calculated number of axons/optic nerve (ON). The arrow indicates an injured area in the optic nerve, characterized by the absence of well-formed myelinated axons (n = 7 and 6, respectively; *P = 4.9×10−2). Scale bars: 25 μm.
Figure 3
Figure 3. Intraocular pressure (IOP) increases with age in sGCα1 −/− mice.
IOP, measured serially at 2 time points (19±1 and 37±3 weeks) in eyes from age-matched wild-type (WT, left panel) and soluble guanylate cyclase α1-deficient (sGCα1 −/−) mice (right panel). While IOP remained stable in WT mice as they aged from 19 to 37 weeks (14±2 to 14±2 mmHg; n = 25; P = 0.67), IOP increased in sGCα1 −/− mice (14±2 to 18±3 mmHg; n = 37; *P = 1.9×10−8).
Figure 4
Figure 4. Morphology of the cornea and anterior segment does not differ in WT and sGCα1 −/− mice. A
: Representative light microscopic images of the central cornea in wild-type (WT, left) and soluble guanylate cyclase α1-deficient mice (sGCα1 −/−, right). Central corneal thickness (CCT) was similar in age-matched WT and sGCα1 −/− mice. Double arrows: CCT. Scale bar: 200 μm. B: Representative ultrasound biomicroscopy images of the ocular anterior segment, obtained in WT (upper panel) and sGCα1 −/− mice (lower panel). The cornea, iris, vitreous, and lens are evident. Depth of the anterior chamber (DAC, double arrow) did not differ in WT and sGCα1 −/− mice. C and D: Representative light microscopic images of paraffin sections stained with hematoxylin and eosin (C, scale bar: 100 μm) or Toluidine Blue (D, scale bar: 50 μm) containing the iridocorneal angles of 12-month-old WT (left panels) and sGCα1 −/− mice (right panels). Location of the cornea, iris root, ciliary body (CB), anterior chamber (AC), and posterior chamber (PC) are indicated. E: Representative SD-OCT images of the ocular anterior segment, obtained in a 12-month-old wild-type mouse (upper panel), a 12-month-old sGCα1 −/− mouse (middle panel), and a 12-month-old DBA2/J mouse in which the angle is closed (lower panel). SD-OCT revealed no morphological abnormalities in sGCα1−/− mice that would suggest a closed angle as detected in old DBA2/J mice. See also Movies S1, S2, S3.
Figure 5
Figure 5. Decreased aqueous humor outflow rate in sGCα1 −/− mice. A
: Shown is a representative series of images captured from 57-week-old wild-type (WT) and soluble guanylate cyclase α1-deficient (sGCα1 −/−) mice at 10-minute intervals after application of fluorescein. Scale bars: 2 mm. B: In 12-week-old WT and sGCα1−/− mice with similar IOPs (16±2 and 16±1 mmHg in n = 9 and 8, respectively; P = 0.91) the rate of AqH outflow did not differ, as shown by similar relative fluorescent intensities at all time points measured (P = 0.99) and similar exponential decay constants (0.0098 min−1 (r 2 = 0.997) and 0.0096 min−1 (r 2 = 0.998), respectively; P = 0.12). C: IOP was greater in 57-week-old sGCα1−/− mice than in age-matched WT mice (18±2 mmHg and 16±1, respectively; n = 10 each; P = 0.043), and AqH clearance was delayed in sGCα1−/− mice, as shown by a lower exponential decay constant (0.0058 min−1 (r 2 = 0.972) versus 0.0092 min−1 (r 2 = 0.976), respectively; P = 0.0056) and higher fluorescent intensities at all time points measured. *P = 0.033, 0.0006, 0.024, 0.0029, 0.035, 0.025, between WT and sGCα1 −/− mice at 10, 20, 30, 40, 50, and 60 minutes, respectively.
Figure 6
Figure 6. Retinal vascular dysfunction in sGCα1 −/− mice. A
: Representative trace depicting the diameter in one segment of a retinal arteriole in a wild-type (WT) mouse before, during (arrow), and after injection of the NO-donor compound sodium nitroprusside. Dashed lines indicate the diameter before and after sodium nitroprusside injection. B: Quantitative analysis of the change in diameter (double arrow in fig. 6A) induced by injection of 0.8 mg/kg sodium nitroprusside in WT and sGCα1 −/− mice. n = 5 mice (3–4 arterioles per mouse were assessed, see also fig. S3). *P = 4.1×10−3.

References

    1. Weinreb RN, Khaw PT (2004) Primary open-angle glaucoma. Lancet 363: 1711–1720. - PubMed
    1. Quigley HA (2011) Glaucoma. Lancet 377: 1367–1377. - PubMed
    1. Vajaranant TS, Pasquale LR (2012) Estrogen deficiency accelerates aging of the optic nerve. Menopause 19: 942–947. - PMC - PubMed
    1. Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, et al. (2002) The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21: 359–393. - PubMed
    1. Kass MA, Gordon MO, Gao F, Heuer DK, Higginbotham EJ, et al. (2010) Delaying Treatment of Ocular Hypertension: The Ocular Hypertension Treatment Study. Arch Ophthalmol 128: 276–287. - PMC - PubMed

Publication types

MeSH terms